期刊文献+

液相色谱-串联质谱法测定老年人血浆中石杉碱甲的浓度 被引量:4

Quantitation of huperzine A in human plasma by LC - MS/MS for elderly population
原文传递
导出
摘要 目的建立测定老年人血浆中石杉碱甲的液相色谱-串联质谱方法。方法在血浆中加入内标石杉碱乙,用乙腈直接沉淀蛋白法处理样品。采用SeQuant ZIC-HILIC(100mm×2.1mm I.D,3.5μm)色谱柱进行分离,柱温35℃;流动相为含5 mmol·L^(-1)甲酸铵0.1%甲酸水溶液-乙腈(35:65,V/V),流速0.3 mL·min^(-1),柱温35℃,梯度洗脱,进样体积5μL;正离子多反应检测(MRM),离子通道分别为m/z 243.2→210.2(石杉碱甲),m/z 257.2→198.6(石杉碱乙)。结果石杉碱甲线性范围0.05~10μg·L^(-1)(r>0.999),定量下限0.05μg·L^(-1),提取回收率在81.0%~95.4%,批内、批间精密度RSD均小于8%,内标校正基质因子在2.11~2.28。主要药动学参数t_(max)为(2.2±0.7)h,ρ_(max)为(0.9±0.2)μg·L^(-1),t_(1/2)为(14.1±2.0)h,AUC_(0-∞)为(15.3±4.5)μg·h·L^(-1)。结论本方法操作简便、特异性强、灵敏度高,适用于石杉碱甲在老年人中的药动学研究。 AIM To establish a method for determination of huperzine A in human plasma by LC-MS/MS for elder population. METHODS After addition of huperzine B (internal standard), the plasma was processed by direct protein precipitation. The chromatographic separation was performed on SeQuant ZIC- HILIC Column ( 100 mm x 2.1 mm I.D, 3.5 μm) column with a mobile phase of 5 mmol.L-1 ammonium formate and 0.1% formic acid solutionacetonitrile (35 : 65, V/V) in water. Flow rate was 0.3 mL.min-1 and column temperature was kept at 35 ℃. Isocratic elution and the injection volume was 5 μL. The protonated ions of analytes weredetected in positive ionization through multiple reaction monitoring mode (MRM). The mass transition pairs of m/z 243.2 - 210.2 and rrdz 257.2 - 198.6 were used to detect huperzine A and huperzine B respectively. RESULTS The linear concentration ranges of the calibration curve was 0.05 to 10 μg. L-1 and the low limit of quantitation was 0.05 μg L-1 for huperzine A (r 〉 0.999) . The extraction recovery rates were ranged from 81.0% to 95.4%, within-batch RSD and between-batch RSD were less than 8%, the matrix effect factor of 2.11 - 2.28. The main pharmacokinetics were as follows: (2.2 ± 0.7) h, p (0.9 ± 0.2) (14.1 ± 2.0) h and AUCo(15.3 ± 4.5) μg.h.L-L CONCLUSION simple and quick, with high specificity and sensitivety, suitable cokinetics in elder people. The pretreatment with LC-MS/MS method is for the research of huperzine A pharmacokinetics in elder people.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2012年第12期728-731,共4页 Chinese Journal of New Drugs and Clinical Remedies
基金 中国科学院上海药物研究所临床研究中心基金项目(SIMMCRC2010001)
关键词 石杉碱甲 色谱法 高压液相 串联质谱法 血浆 老年人 agedhuperzine A chromatography, high pressure liquid tandem mass spectrometry plasma
  • 相关文献

参考文献6

  • 1HA GT, WONG RK, ZHANG Y. Huperzine a as potential treatment of Alzheimer's disease: an assessment on chemistry, pharmacology, and clinical studies[J]. Chem Biodivers, 2011, 8 (7): 1189-1204.
  • 2TANG XC, DE SARNO P, SUGAYA K, et al. Effect of huperzine A, a new cholinesterase inhibitor, on the central cholinergic system of the rat[J]. J Neurosci Res, 1989, 24(2): 276-285.
  • 3LI YX, ZHANG RQ, LI CR, et al. Pharmacokinetics of huperzine A following oral administration to human volunteers[J]. Eur J Drug Meta Pharmacokinet, 2007, 32(4) : 183-187.
  • 4QIAN BC, WANG M, ZHOU ZF, et al. Pharmacokinetics of tablet huperzine A in six volunteers[J]. Acta pharmacol Sin, 1995, 16(5): 396-398.
  • 5WEI JX, WU JY, WEISS, et al. Determination of huperzine A in human plasma by hydrophilic interaction chromatography coupled to tandem mass spectrometry[J]. Anal Methods, 2011, 3: 1186-1192.
  • 6WU T, LI CY, CHEN M, et al. Clinic pharmacokinetic profiles of huperzine A following transdermal administration to healthy human volunteers[J]. Chromatographia, 2011, 74(1-2): 67-73.

同被引文献57

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部